GENOSS paclitaxel balloon for leg artery disease
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests a special balloon coated with paclitaxel (a drug that helps keep arteries open) in people with narrowed or blocked leg arteries. It aims to see how well the balloon works over one year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have leg symptoms like pain while walking, pain at rest, or sores on your foot or leg (Rutherford stages 2, 3, 4, or 5).
- You have a blocked or narrowed artery in your upper leg or behind the knee (femoropopliteal area).
- You are scheduled to have a balloon procedure to open that artery.
- You have at least one open artery below the knee that supplies blood to your foot (with less than 50% narrowing).
- You are not allergic to paclitaxel or any blood-thinning medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a special balloon coated with a drug (paclitaxel) to treat narrowed or blocked arteries in the leg. It aims to see how well this balloon works to keep the artery open.
This trial is testing a special balloon coated with the drug paclitaxel to open up long blockages in the leg artery (femoropopliteal). The goal is to see if it is safe and effective for improving blood flow and symptoms like pain or ulcers.
This trial tests if using a special 'chocolate' balloon before a drug-coated balloon is better than a standard balloon for opening narrowed or blocked arteries in the leg. It may help people with leg pain or wounds from poor blood flow.
This trial tests a special balloon coated with a drug (paclitaxel) to open blocked leg arteries, aiming to improve blood flow and reduce symptoms like leg pain when walking. It is for people with moderate to severe leg artery disease who have not had prior stents or bypass in the treated area.
This trial is testing a paclitaxel-coated balloon to treat narrowed heart arteries. It aims to see how well the balloon works in a wide range of patients with coronary artery disease who have symptoms or signs of reduced blood flow to the heart.
This study follows people with blocked blood vessels in the thigh and behind the knee to see how well a drug-coated balloon (“Luminor”) works over 5 years. It’s designed to collect real-world results and track safety and outcomes long term.
Hear when a new Femoropopliteal Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.